Empagliflozin as a Novel Therapy in Refractory Ascites

Clinical trial NCT05430243 · COMPLETED

Trial details

NCT number: NCT05430243
Sponsor: Alexandria University
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Ascites Hepatic

Start date: 2022-04-21
Primary completion: 2022-11-12
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.